Atossa Therapeutics is set to participate in the Cantor Fitzgerald Global Healthcare Conference 2023. The company's CEO, Steven Quay, will engage in a fireside chat on September 28th at 9:10 A.M. ET in New York, NY, offering insights into the company's innovative medicines, particularly focused on breast cancer, addressing unmet needs in the field. View the webcast here: https://investors.atossatherapeutics.com.
The Markets by Proactive
Go to Proactive Australia
Proactive’s Australian coverage continues on .com